IFF Reports Q3 Growth, Boosts Guidance, and Attracts Target Hikes

International Flavors & Fragrances Inc. recently posted third-quarter results showing growth across all operating divisions and increased the bottom end of its full-year 2026 financial forecast. Revenue reached $1.94 billion, rising roughly 5% on a comparable currency-neutral basis and 3.9% year over year. The company reported adjusted earnings per share of $0.83, exceeding analyst forecasts of $0.81. Quarterly EBITDA grew 6% on a comparable currency-neutral basis to $403 million, supported by volume contributions.

Segment performance was led by Taste, where sales increased 6% to $687 million with EBITDA up 7% to $128 million. Scent sales also rose 6% to $689 million, delivering a 10% EBITDA gain to $139 million. Health & Biosciences generated $566 million in sales, up 1%, with EBITDA rising 2% to $139 million. For the full year, management updated guidance to projected sales between $7.5 billion and $7.6 billion and adjusted operating EBITDA of $1.55 billion to $1.6 billion, lifting the floor for both metrics.

Cash generation improved during the first nine months of 2026, with free cash flow reaching $371 million, an increase of $245 million over the previous year. Operating cash flow totaled $820 million. The company completed a $500 million accelerated share repurchase program, retiring around 5.8 million shares, and its board approved a broader $2.5 billion share repurchase authorization. IFF reported that its Food Ingredients divestiture remains on track to finish by the conclusion of the first half of 2027.

Following the release, Wall Street research firms adjusted their outlooks. JPMorgan Chase & Co. lifted its price target from $92.00 to $95.00 with an overweight rating, while Citigroup raised its target to $105.00 with a buy rating. UBS Group boosted its target from $91.00 to $95.00 while maintaining a neutral stance. MarketBeat data recorded an average analyst target of $94.99 and a consensus rating of Moderate Buy, though some reports pointed to cautious near-term profit expectations and higher costs as potential headwinds.

IFF shares experienced volatile trading, falling 4.3% to $82.62 on November 06, 2026. A GuruFocus report published on November 07 designated the equity as significantly overvalued relative to its GF Value estimate of $62.69, noting a price-to-earnings ratio of 117.2x. However, the report also highlighted significant insider activity, including $31.2M in net insider purchases over the preceding twelve months alongside multiple institutional position increases.